NCT06314711View on ClinicalTrials.gov

Ex Vivo 3D-ultrasound for Oropharyngeal Cancer

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions
Oropharyngeal Squamous Cell Carcinoma
Interventions
DIAGNOSTIC_TEST

Ultrasound

High-frequency ultrasound of ex vivo specimen

Trial Locations (1)

2100

Dept. of Otorhinolaryngology, Head & Neck Surg, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT06314711 - Ex Vivo 3D-ultrasound for Oropharyngeal Cancer | Biotech Hunter | Biotech Hunter